MDGL Return on Tangible Equity | MADRIGAL PHARMACEUTICALS, INC.

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Return on Tangible Equity

2026-06-30: Return Tang Equity -62.94%.
2026-03-31: Return Tang Equity -57.71%.
2025-12-31: Return Tang Equity -48.43%.
2025-09-30: Return Tang Equity -46.76%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-62.94%
2026-03-31	-57.71%
2025-12-31	-48.43%
2025-09-30	-46.76%
2025-06-30	-40.77%
2025-03-31	-55.47%
2024-12-31	-62.15%
2024-09-30	-67.16%
2024-06-30	-59.90%
2024-03-31	-52.53%
2023-12-31	-92.18%
2023-09-30	-1561.15%
2023-06-30	-318.63%
2023-03-31	-209.63%
2022-12-31	-149.63%
2022-09-30	-2567.89%
2022-06-30	-306.34%
2022-03-31	-169.35%
2021-12-31	-123.32%
2021-09-30	-100.66%
2021-06-30	-85.45%
2021-03-31	-83.92%
2020-12-31	-84.28%
2020-09-30	-58.98%
2020-06-30	-39.17%
2020-03-31	-27.24%
2019-12-31	-20.15%
2019-09-30	-15.37%
2019-06-30	-11.98%
2019-03-31	-8.86%
2018-12-31	-6.88%
2018-09-30	-6.17%
2018-06-30	-6.10%
2018-03-31	-17.79%
2017-12-31	-17.09%
2017-09-30	-56.08%
2017-06-30	-56.14%
2017-03-31	-102.53%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-48.43%
2024-12-31	-62.15%
2023-12-31	-92.18%
2022-12-31	-149.63%
2021-12-31	-123.32%
2020-12-31	-84.28%
2019-12-31	-20.15%
2018-12-31	-6.88%
2017-12-31	-17.09%
2016-12-31	-72.47%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BIOMARIN PHARMACEUTICAL INC (BMRN)	United States	$11.879B	151.80
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05